Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

Tailored letters boost breast cancer screening in Hard-to-Reach women

NCT ID NCT07472036

Knowledge-focused Sponsor: Universiteit Antwerpen Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed This study
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study looked at whether sending a culturally and linguistically tailored reminder letter could increase breast cancer screening among women aged 50-69 who had never been screened before. About 8,000 women were split into two groups: one got the standard invitation only, the other got an extra personalized reminder. The researchers measured how many women got a mammogram within 40 days, and whether the effect was different for women with lower versus higher socioeconomic status.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

7,947 people

The number who actually took part.

Started

Apr 2024

Finished

Dec 2025

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

50 to 69 years

Sex

Anyone

Healthy volunteers

Accepted

You do not need to have the condition being studied to take part.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria Individual-level criteria: * Aged 50-69 years * Legally registered as female in the Belgian national population registry * No history of breast cancer in the previous 10 years * No bilateral mastectomy in the previous 10 years * Invited for mammography between April and June 2024 * Classified as a non-attender, defined as (1) having received at least one previous screening invitation, and (2) never having participated in the screening program. Area-level criteria: To increase the inclusion of socioeconomically vulnerable individuals while maintaining representation from the broader screening population, participants are selected from the list of individuals invited at mammographic units located in municipalities with high deprivation scores, defined as meeting at least two of the following criteria: * Average income per capita \< EUR 20,000 * Belgian Multiple Index of Deprivation score \< 6 * Proportion of residents eligible for increased reimbursement for medical expenses \> 12%. Exclusion Criteria * Actively opted out of the screening program at the time of the study * Invited for screening in the previous year * Underwent mammographic screening in the previous year

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Breast cancer screening are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

breast neoplasm Health Behavior

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Breast cancer screening Health behavior Mammography

Contacts and locations

Locations

  • Centre for Cancer Detection (CvKO)

    Bruges, Belgium

  • University of Antwerp

    Antwerp, 2000, Belgium

More trials for these conditions

Other studies related to the condition(s) this trial covers.